US20020013472A1 - Oxyranyle-triazoline thiones and their use as microbicides - Google Patents

Oxyranyle-triazoline thiones and their use as microbicides Download PDF

Info

Publication number
US20020013472A1
US20020013472A1 US09/827,058 US82705801A US2002013472A1 US 20020013472 A1 US20020013472 A1 US 20020013472A1 US 82705801 A US82705801 A US 82705801A US 2002013472 A1 US2002013472 A1 US 2002013472A1
Authority
US
United States
Prior art keywords
carbon atoms
formula
oxiranyl
butyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/827,058
Other versions
US6414007B2 (en
Inventor
Stefan Hillebrand
Manfred Jautelat
Astrid Mauler-Machnik
Klaus Stenzel
Martin Kugler
Otto Exner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823861A external-priority patent/DE19823861A1/en
Application filed by Individual filed Critical Individual
Priority to US09/827,058 priority Critical patent/US6414007B2/en
Publication of US20020013472A1 publication Critical patent/US20020013472A1/en
Application granted granted Critical
Publication of US6414007B2 publication Critical patent/US6414007B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/38Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Definitions

  • the present invention relates to novel oxiranyl-triazolinetlhiones, to a process for their preparation and to their uses as microbicides.
  • This invention accordingly, provides novel oxiranyl-triazolinethiones of the formula
  • R 1 requests alkyl having 1 to 4 carbons atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, optionally haolgen-subsituted cycloalkyl having 3 to 7 carbon atoms, naphthyl or phenyl which is optionally mono-to trisubstituted by identical or different substituents from the group consisting of halogen, nitro, phenyl, phenoxy, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon adoms, halogenoalky having 1 to 4 carbon atoms and 1 to 5 halogen atoms, halogenoalkoxy having 1 to 4 carbon atoms and 1 to 5 halogen atoms and halogenoalkylthio having 1 to 4 carbon atoms and 1 to 5 halogen atoms, R 2 represents phenyl which is optionally mono-to trisubstituted by identical or different
  • the substances according to the invention contain two asymmetrically substituted carbon atoms and can therefore be obtained in the form of diastereomers or enantionmiers.
  • the present invention relates both to the individual isomers and to their mixtures.
  • R 3 is as defined above, if appropriate in the presence of a catalyst and if appropriate in the presence of a diluecnt.
  • novel oxiranyl-triazolinethiones of the formula (1) or ( 1 a ) have very good microbicidal properties and can be use both in crop protection and in the protection of materials for controlling undesirable microorganisms.
  • the oxiranyl-triazolinethiones of the fonnula (I) or (Ia) according to the invention have better inicrobicidal activity, in particular fungicidal activity, than the constitutionally most similar prior-art compounds of the same direction of action
  • the substances according to the invention stirlpass 3-(2-chloro-plhenyl)-2-(4-fluoro-plhenyl)-2-[(4,5-dilydro-5-thiono-1,2,4-triazol-I -yl)-metlhyl]-oxirane with respect to the fungicidal properties.
  • R 1 preferably represents methyl, ethyl, n-propyl, isopiropyl, n-buttyl, sec-butyl, iso-butyl, tert-butyl, fluoro-tert-butyl, difuoro-tert-butyl, cycloalkyl having 3 to 6 carbon atoms which is optionally mono-to tristubstituted by identical or different substituents from the group consisting of fluorine, chlorine and bromine, preferably represents naphthyl or preferably represents phenyl which may be mono-to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, nitro, phenyl, phenoxy, methyl, ethyl, tert-butyl, metlhoxy,
  • R 1 represents phenlyl which may be mono-to trisuLtstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, nitro, phenyl, phenoxy, methiyl, ethyl, tert-butyl, mtchoxy, ethoxy, trifluoronietlyl, trichloroiiietliyl, (ifluoromiiethyl, di fluorochloromettiyl, trifluoromethoxy, difluoromethoxy and trifluoromethylthio
  • R 2 represents plicnyl which may be mono-to trisubstituted by identical or different subtstituenits from tlhc group consisting of fluorine, chlorine, bromine, methlyl, ethyl, isopropyl, tert-butyl, methoxy, ethoxy, trifluoromethyl, trichloromethyl
  • oxirane derivatives required as starting materials for preparing the substances according to the invention can be present in the “thiono” form of the formula
  • the substances according to the invention can be derived both from the “thiono” form of the formula (II) and frorm the “mercapto” form of the formula (IIa). This means that the substances according to the invention are either present as substances of the formula
  • the formula (II) or (IIa) provides a general definition of the oxirane derivatives required as starting materials for carrying out the process according to tile invention.
  • R 1 and R 2 preferably have those meanings which have already been mentioned in connection with the description of the substances of tile formnula (I) or (Ia) according to thle invention as being preferred for these radicals.
  • the formula (III) provides a general definition of the isocyaniates required as reaction components for carrying out the process according to the inveIntion.
  • R 3 preferably has those meanings which have already been mentioned in connection with the description of thle substances of tile formula (I) according to the invention as being preferred for this radical.
  • Suitable catalysts for carrying out the process according to the invention are all reaction promoters which are customary for such reactions. Preference is given to using amines, such as triethylamine, pyridine, dimethylaminopyridine and diazabicyclo-undecene (DBU).
  • amines such as triethylamine, pyridine, dimethylaminopyridine and diazabicyclo-undecene (DBU).
  • Suitable diluents for carrying out the process according to the invention are all inert organic solvents which are customary for such reactions. Preference is given to using aromatic hydrocarbons, such as toluene, xylene or decaline, also halogenated hydrocarbons, such as dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichlioroethane, moreover ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane or tetrahydrofuran, and furthermore nitriles, such as acetonitrile, propionitrile, n-or iso-butyronitrile.
  • aromatic hydrocarbons such as toluene, xylene or decaline
  • halogenated hydrocarbons such as dichloromethane, chloroform, carbon t
  • reaction temperatures can be varied within a certain range.
  • the process is carried out at temperatures between ⁇ 20° C. and +100° C., preferably between 0° C. and +80° C.
  • the process according to the invention is generally carried out under atmospheric pressure. However, it is also possible to carry out the process under elevated pressure or, if no highly volatile components are taking part in the reaction, also under reduced pressure.
  • the compounds according to the invention have a potent microbicidal activity and can be employed for controlling undesirable microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.
  • Fungicides are employed in crop protection for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygoniycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
  • Bactericides are employed in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
  • Xanthonionas species such as, for example, Xanthomonas campestris pv. oryzae
  • Pseudomonas species such as, for example, Pseudomonas syringae pv.
  • Erwinia species such as, for example, Erwinia amylovora
  • Pythium species such as, for example, Pythium ultimum
  • Phytophtlhora species such as, for example, Phytoplhthora infestans
  • Pseudoperonospora species such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis
  • Plasmopara species such as, for example, Plasmopara viticola
  • Bremia species such as, for example, Bremia lactucae
  • Peronoslpora species such as, for example, Peronospora pisi or P.
  • Erysiphe species such as, for example, Erysiphe graminis
  • Sphaerotheca species such as, for example, Sphaerotheca fuliginea
  • Podosphaera species such as, for example, Podosphaera leucotricha
  • Venturia species such as, for example, Venturia inaequalis
  • Pyrenophora species such as, for example, Pyrenophora tercs or P.
  • graminea conidia form: Drechslera, syn: Helminthosporium
  • Cochlioboltis species such as, for example, Cochiliobolus sativus (conidia form: Drechslera, syn: Helminthosporium ); Uromyces species , such as, for example, Uromyces appendiculatus; Puccinia species , such as, for example, Puccinia recondita; Sclerotinia species , such as, for example, Sclerotinia sclerotiorum Tilletia species , such as, for example, Tilletia caries; Ustilago species , such as, for example, Ustilago nuda or Ustilago avenae; Pellicularia species , such as, for example, Pellicularia sasakii; Pyricularia species , such as, for example, Pyricularia oryzae; Fusarium species , such as, for, for
  • the active compounds according to the invention can be employed in particular for controlling Pyticularia oryzae on rice and for controlling cereal diseases, such as Puccinia, Erysipie and Fusarium species .
  • the substances according to the invention can be used successfully against Venturia, Podosphaera and Sphaerotheca . They also have very good in-vitro action.
  • the active compounds according to the invention may also be employed to increase the yield of crops. Moreover, they have low toxicity and are well tolerated by plants.
  • the compounds according to the invention can be employed for protecting industrial materials against infection with, and destruction by, undesired microorganisms.
  • Industrial materials in the present context are understood as meaning non-living materials which have been prepared for use in industry.
  • industrial materials which are intended to be protected by active compounds according to the invention from microbial change or destruction can be adhesives, sizes, paper and board, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be infected with, or decomposed by, microorganisms.
  • Parts of production plants, for example cooling-water circuits, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected.
  • Industrial materials which may be mentioned within the scope of the present invention are preferably adhesives, sizes, paper and board, leather, wood, paints, cooling lubricants and heat-transfer liquids, particularly preferably wood.
  • Microorganisms capable of degrading or changing the industrial materials which may be mentioned are, for example, bacteria, fungi, yeasts, algae and slime organisms.
  • the active compounds according to the invention preferably act against fungi, in particular moulds, wood-discolouring and wood-destroying fungi ( Basidiomycetes ), and against slime organisms and algae.
  • Microorganisms of the following genera may be mentioned as examples: Alternaria , such as Altemaria tentis, Aspergillus , such as Aslpergillus niger, Chaetomium , such as Chaetomium globosum, Coniophora , such as Coniophora puetania, Lentinus , such as Lentinus tigriitis, Pcenicilliutmi , such as Penicillium glaucum, Polyponis , such as Polyponis vcrsicolor, Aureobasidium , such as Aureobasidium pullulans, Sclerophoma , such as Sclerophoma pityophilIa, Trichoderma , such as Trichioderma viride, Eschierichia , such as Eschericihia coli, Pseudomonas , such as Pseudomonas aeruginosa , and Staphylococc
  • the active compounds can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
  • customary formulations such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
  • formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, liquefied gases under pressure, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam fonners. If the extender used is water, it is also possible to use for example organic solvents as auxiliary solvents.
  • extenders that is, liquid solvents, liquefied gases under pressure, and/or solid carriers
  • surfactants that is emulsifiers and/or dispersants, and/or foam fonners.
  • the extender used is water, it is also possible to use for example organic solvents as auxiliary solvents.
  • liquid solvents aromatics such as xylene, toluene or alkylnaptlilialenies, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as clilorobenizenies, cliloroethylenes or methylcne chloride, alipphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, alcohols such as butanlol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylfoniamide or dimethiyl sulphioxide, or else wvater.
  • aromatics such as xylene, toluene or alkylnaptlilialenies
  • chlorinated aromatics or chlorinated aliphatic hydrocarbons such as clilorobenizenies, cliloroethylenes or methyl
  • Liquefied gaseous extenders or carriers are to be understood as meaning liquids which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, or else butane, propane, nitrogen and carbon dioxide.
  • Suitable solid carriers are: for example ground natural minerals such as kaolins, clays, talc, chalk, quartz, attalpulgite, monitirorillonite or cliatomaceous earth, and ground synthetic minerals such as highly disperse silica, alumina and silicates.
  • Suitable solid carriers for granules are: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, or else synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks.
  • Suitable emulsifiers and/or foam formers are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, or else protein hydrolysates.
  • Suitable dispersants are: for example lignin-sulphite waste liquors and methylcellulose.
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in the formulations.
  • Other additives can be mineral and vegetable oils.
  • colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phtlialocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phtlialocyanine dyestuffs
  • trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations generally comprise between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%.
  • the active compounds according to the invention can be used as such or, in their formulations, also mixed with known fungicides, hactcricidcs, acaricides, nemiiaticides or insecticides in order thus, for example, to Widen the spectrum of action or to prevent development of resistance. In many cases, synergistic effects are achieved here, i.e. the activity of the mixture exceeds the activity of the individual components.
  • Fungicides aldimorph, ampropylfos, ampropylfos potassium, andoprim, anilazine, azaconazole, azoxystrobin, benalaxyl, benodanil, benomyl, benzamacril, benzamacril-isobutyl, bialaphos, binapacryl, biplienyl, bitertanol, blasticidini-S, bromuconazole, bupirimate, buthiobate, calcium polysuiphide, capsimycin, captafol, captan, carbendazim, carboxin, carvon, quinomethionate, chlobenthiazone, chlorfenazole, chlioroneb, chloropicrin, chlorotlalonil, chlozolinate, clozylacon, cufraneb, cymoxanil, cyproconazole
  • the active compounds can be used as such or in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. They are used in the customary manner, for example by pouring, spraying, atomizing, spreading, dusting, foaming, bnishilg on and the like. It is further possible to apply the active compounds by the ultra-low volume method or to inject the active compound formulation, or the active compound itself, into the soil. The seeds of the plants can also be treated.
  • the application rates can be varied within a relatively wide range, depending on the type of application.
  • the active compound application rates are generally between 0.1 and 10,000 g/ha, prefcrably between 10 and 1000 g/ha.
  • the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably bctwecn 0.01 and 10 g per kilogram of seed.
  • the active compound application rates are generally between 0.1 and 10,000 gha, preferably between 1 and 5000 g/ha.
  • compositions used for protecting industrial materials generally comprise the active compounds in an amount of from 1 to 95% by weight, preferably from 10 to 75% by weight.
  • the use concentrations of the active compounds according to the invention depend on the species and the occurrence of the microorganisms to be controlled, and on the composition of the material to be protected.
  • the optimum amount to be used can be determined by test series.
  • the use concentrations are in the range from 0.001 to 5% by weight, preferably from 0.05 to 1.0% by weight, based on the material to be protected.
  • Example 1 TABLE 2 (I) Example Melting point No. R 1 R 2 R 3 in ° C. 2 —CH 2 —CH 2 —O—CH 3 105-107 3 —CH(CH 3 ) 2 104-106 4 —C 12 H 25 -n 53-57 5 —CH(CH 3 ) 2 100-101 6 —CH 2 —CH 2 —O—CH 3 96-98
  • the plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules.
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, vhereas an efficacy of 100% means that no infections are observed.
  • the plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules.
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed.
  • the plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules.
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed.
  • Leptosphaeria nodorum test (wheat)/protective Solvent 25 parts by weight of N,N-dimethylacetamide
  • Emulsifier 0.6 parts by weight of alkylaryl polyglycol ether
  • the plants are placed in a greenhouse at a temperature of approximately 15° C. and a relative atmospheric humidity of 80%.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed.
  • the plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of rust pustules.
  • the plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of rust pustules.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed.
  • Podosphaera test (apple)/protective Solvent 47 parts by weight of acetone
  • Emulsifier 3 parts by weight of alkylaryl polyglycol ether
  • An agar prepared by using malt extract peptone, is mixed in a liquid state with the preparation of active compound at the particular desired application rate. After solidification, the resultant nutrient medium is incubated at 26° C. with mycelium pieces punched out of colonies of Coriolus versicolor.
  • Evaluation is carried out after 3 or 7 days' storage at 26° C. by measuring the growth of the mycelium and scoring the resulting inhibition in percent in comparison to the untreated control. 0% means an inhibition of growth which corresponds to that of the untreated control, while an inhibition of growth of 100% means that no growth of mycelium is observed.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Novel oxiranyl-triazolinethiones of the formula
Figure US20020013472A1-20020131-C00001
in which R1, R2 and R3 are each as defined in the description, a process for preparing the novel substances and their use as microbicides in crop protection and in the protection of materials.

Description

    The present invention relates to novel oxiranyl-triazolinetlhiones, to a process for their preparation and to their uses as microbicides.
  • It is already known that numerous azclylmethyl-oxirane derivatives have fungicidal properties (cf. EP-A 0 094 564, EP-A 0 196 038 and WO-A 96-38 440). Thus, for example, 3-(2-chloro-phenyl)-2-(4-fluoro-phenyl)-2-[(4,5-dihydro-5-thiono-1,2,4-triazol-1-yl)-methyl]-oxirane can be used for controlling fungi. The activity of this substance is good; however, it is sometimes unsatisfactory at low application rates. [0001]
  • This invention, accordingly, provides novel oxiranyl-triazolinethiones of the formula [0002]
    Figure US20020013472A1-20020131-C00002
  • in which R[0003] 1 requests alkyl having 1 to 4 carbons atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, optionally haolgen-subsituted cycloalkyl having 3 to 7 carbon atoms, naphthyl or phenyl which is optionally mono-to trisubstituted by identical or different substituents from the group consisting of halogen, nitro, phenyl, phenoxy, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon adoms, halogenoalky having 1 to 4 carbon atoms and 1 to 5 halogen atoms, halogenoalkoxy having 1 to 4 carbon atoms and 1 to 5 halogen atoms and halogenoalkylthio having 1 to 4 carbon atoms and 1 to 5 halogen atoms, R2 represents phenyl which is optionally mono-to trisubstituted by identical or different substituents from the group consisting of halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, halogenoalkoxy having 1 to 4 carbon atoms and 1 to 5 halogen atoms and halogenoalkylthio having 1 to 4 carbon atoms and 1 to 5 halogen atoms and R3 represents alkoxyalkyl, isopropyl or n-dodecyl.
  • The substances according to the invention contain two asymmetrically substituted carbon atoms and can therefore be obtained in the form of diastereomers or enantionmiers. The present invention relates both to the individual isomers and to their mixtures. [0004]
  • Furthermore, it has been found that oxiranyl-triazolinethionics of the formula (1) or ([0005] 1 a) are obtained when oxirane derivatives of the formula
    Figure US20020013472A1-20020131-C00003
  • in which R[0006] 1 and R2 are each as defined above are reacted with isocyanates of the formula
  • R3-NCO  (III)
  • in which R[0007] 3 is as defined above, if appropriate in the presence of a catalyst and if appropriate in the presence of a diluecnt.
  • Finally, it has been found that the novel oxiranyl-triazolinethiones of the formula (1) or ([0008] 1 a) have very good microbicidal properties and can be use both in crop protection and in the protection of materials for controlling undesirable microorganisms.
  • Surprisingly, the oxiranyl-triazolinethiones of the fonnula (I) or (Ia) according to the invention have better inicrobicidal activity, in particular fungicidal activity, than the constitutionally most similar prior-art compounds of the same direction of action Thus, the substances according to the invention stirlpass 3-(2-chloro-plhenyl)-2-(4-fluoro-plhenyl)-2-[(4,5-dilydro-5-thiono-1,2,4-triazol-I -yl)-metlhyl]-oxirane with respect to the fungicidal properties. [0009]
  • The formula (I) or (la) provides a general definition of the oxiranlyl-triazolinetlhiones according to the invention. R[0010] 1 preferably represents methyl, ethyl, n-propyl, isopiropyl, n-buttyl, sec-butyl, iso-butyl, tert-butyl, fluoro-tert-butyl, difuoro-tert-butyl, cycloalkyl having 3 to 6 carbon atoms which is optionally mono-to tristubstituted by identical or different substituents from the group consisting of fluorine, chlorine and bromine, preferably represents naphthyl or preferably represents phenyl which may be mono-to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, nitro, phenyl, phenoxy, methyl, ethyl, tert-butyl, metlhoxy, ethioxy, trifluoromethyl, trichloromethyl, difluoromethyl, dilluorochloromethyl, trifluoromethoxy, difluoromethoxy and tri fluoromethylthio, R2 preferably represents phenyl which may be mono-to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, metlhyl, ethyl, isoprolpyl, tert-butyl, methioxy, ethoxy, trifluorometllyl, triclhloromethyl, difluorometlhyl, difluorochloromethyl, trifuorometlhoxy, difluoromethloxy and trifluorometlhylthio, and R3 preferably represents alkoxyalkyl having 1 to 6 carbon atoms in the alkoxy moiety and 1 to 6 carbon atoms in the alkyl moiety and also preferably represents isopropyl or n-dodecyl.
  • Particular preference is given to oxiranyl-triazolinetthioncs of the formula (1) or (la) in which [0011]
  • R[0012] 1 represents phenlyl which may be mono-to trisuLtstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, nitro, phenyl, phenoxy, methiyl, ethyl, tert-butyl, mtchoxy, ethoxy, trifluoronietlyl, trichloroiiietliyl, (ifluoromiiethyl, di fluorochloromettiyl, trifluoromethoxy, difluoromethoxy and trifluoromethylthio, R2 represents plicnyl which may be mono-to trisubstituted by identical or different subtstituenits from tlhc group consisting of fluorine, chlorine, bromine, methlyl, ethyl, isopropyl, tert-butyl, methoxy, ethoxy, trifluoromethyl, trichloromethyl, difluoromethyl, difluorochloronmethyl, trifluoromethoxy, difluoromethloxy and trifluoromethylithio, and R3 represents alkoxyalkyl having 1 to 4 carbon atoms in the alkoxy moiety and 1 to 4 carbon atoms in the alkyl moiety and also represents isopropyl or n-dodecyl.
  • The substituent definitions mentioned can be combined with one another at will. Moreover, individual definitions may not apply. [0013]
  • The oxirane derivatives required as starting materials for preparing the substances according to the invention can be present in the “thiono” form of the formula [0014]
    Figure US20020013472A1-20020131-C00004
  • or in the talitorneric “mercapto” form of the formula [0015]
    Figure US20020013472A1-20020131-C00005
  • It is therefore possible that the substances according to the invention can be derived both from the “thiono” form of the formula (II) and frorm the “mercapto” form of the formula (IIa). This means that the substances according to the invention are either present as substances of the formula [0016]
    Figure US20020013472A1-20020131-C00006
  • or of the formula [0017]
    Figure US20020013472A1-20020131-C00007
  • or as mixtures of the formulae (I) and (Ia). [0018]
  • Examples of substances according to the invention hvliiclh may be mentioned are the oxiranyl-triazoliiietliones listed in the table below. [0019]
    TABLE 1
    (I)
    Figure US20020013472A1-20020131-C00008
    or
    (Ia)
    Figure US20020013472A1-20020131-C00009
    R1 R2 R3
    Figure US20020013472A1-20020131-C00010
    Figure US20020013472A1-20020131-C00011
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00012
    Figure US20020013472A1-20020131-C00013
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00014
    Figure US20020013472A1-20020131-C00015
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00016
    Figure US20020013472A1-20020131-C00017
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00018
    Figure US20020013472A1-20020131-C00019
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00020
    Figure US20020013472A1-20020131-C00021
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00022
    Figure US20020013472A1-20020131-C00023
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00024
    Figure US20020013472A1-20020131-C00025
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00026
    Figure US20020013472A1-20020131-C00027
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00028
    Figure US20020013472A1-20020131-C00029
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00030
    Figure US20020013472A1-20020131-C00031
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00032
    Figure US20020013472A1-20020131-C00033
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00034
    Figure US20020013472A1-20020131-C00035
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00036
    Figure US20020013472A1-20020131-C00037
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00038
    Figure US20020013472A1-20020131-C00039
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00040
    Figure US20020013472A1-20020131-C00041
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00042
    Figure US20020013472A1-20020131-C00043
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00044
    Figure US20020013472A1-20020131-C00045
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00046
    Figure US20020013472A1-20020131-C00047
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00048
    Figure US20020013472A1-20020131-C00049
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00050
    Figure US20020013472A1-20020131-C00051
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00052
    Figure US20020013472A1-20020131-C00053
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00054
    Figure US20020013472A1-20020131-C00055
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00056
    Figure US20020013472A1-20020131-C00057
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00058
    Figure US20020013472A1-20020131-C00059
    —CH2—CH2—O—C2H5
    Figure US20020013472A1-20020131-C00060
    Figure US20020013472A1-20020131-C00061
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00062
    Figure US20020013472A1-20020131-C00063
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00064
    Figure US20020013472A1-20020131-C00065
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00066
    Figure US20020013472A1-20020131-C00067
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00068
    Figure US20020013472A1-20020131-C00069
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00070
    Figure US20020013472A1-20020131-C00071
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00072
    Figure US20020013472A1-20020131-C00073
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00074
    Figure US20020013472A1-20020131-C00075
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00076
    Figure US20020013472A1-20020131-C00077
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00078
    Figure US20020013472A1-20020131-C00079
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00080
    Figure US20020013472A1-20020131-C00081
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00082
    Figure US20020013472A1-20020131-C00083
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00084
    Figure US20020013472A1-20020131-C00085
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00086
    Figure US20020013472A1-20020131-C00087
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00088
    Figure US20020013472A1-20020131-C00089
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00090
    Figure US20020013472A1-20020131-C00091
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00092
    Figure US20020013472A1-20020131-C00093
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00094
    Figure US20020013472A1-20020131-C00095
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00096
    Figure US20020013472A1-20020131-C00097
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00098
    Figure US20020013472A1-20020131-C00099
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00100
    Figure US20020013472A1-20020131-C00101
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00102
    Figure US20020013472A1-20020131-C00103
    —CH2—CH2—O—CH3
    Figure US20020013472A1-20020131-C00104
    Figure US20020013472A1-20020131-C00105
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00106
    Figure US20020013472A1-20020131-C00107
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00108
    Figure US20020013472A1-20020131-C00109
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00110
    Figure US20020013472A1-20020131-C00111
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00112
    Figure US20020013472A1-20020131-C00113
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00114
    Figure US20020013472A1-20020131-C00115
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00116
    Figure US20020013472A1-20020131-C00117
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00118
    Figure US20020013472A1-20020131-C00119
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00120
    Figure US20020013472A1-20020131-C00121
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00122
    Figure US20020013472A1-20020131-C00123
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00124
    Figure US20020013472A1-20020131-C00125
    —(CH2)3—O—CH3
    Figure US20020013472A1-20020131-C00126
    Figure US20020013472A1-20020131-C00127
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00128
    Figure US20020013472A1-20020131-C00129
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00130
    Figure US20020013472A1-20020131-C00131
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00132
    Figure US20020013472A1-20020131-C00133
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00134
    Figure US20020013472A1-20020131-C00135
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00136
    Figure US20020013472A1-20020131-C00137
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00138
    Figure US20020013472A1-20020131-C00139
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00140
    Figure US20020013472A1-20020131-C00141
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00142
    Figure US20020013472A1-20020131-C00143
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00144
    Figure US20020013472A1-20020131-C00145
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00146
    Figure US20020013472A1-20020131-C00147
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00148
    Figure US20020013472A1-20020131-C00149
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00150
    Figure US20020013472A1-20020131-C00151
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00152
    Figure US20020013472A1-20020131-C00153
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00154
    Figure US20020013472A1-20020131-C00155
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00156
    Figure US20020013472A1-20020131-C00157
    —(CH2)3 —O—C2H5
    Figure US20020013472A1-20020131-C00158
    Figure US20020013472A1-20020131-C00159
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00160
    Figure US20020013472A1-20020131-C00161
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00162
    Figure US20020013472A1-20020131-C00163
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00164
    Figure US20020013472A1-20020131-C00165
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00166
    Figure US20020013472A1-20020131-C00167
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00168
    Figure US20020013472A1-20020131-C00169
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00170
    Figure US20020013472A1-20020131-C00171
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00172
    Figure US20020013472A1-20020131-C00173
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00174
    Figure US20020013472A1-20020131-C00175
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00176
    Figure US20020013472A1-20020131-C00177
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00178
    Figure US20020013472A1-20020131-C00179
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00180
    Figure US20020013472A1-20020131-C00181
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00182
    Figure US20020013472A1-20020131-C00183
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00184
    Figure US20020013472A1-20020131-C00185
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00186
    Figure US20020013472A1-20020131-C00187
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00188
    Figure US20020013472A1-20020131-C00189
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00190
    Figure US20020013472A1-20020131-C00191
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00192
    Figure US20020013472A1-20020131-C00193
    —(CH2)3—C—C2H5
    Figure US20020013472A1-20020131-C00194
    Figure US20020013472A1-20020131-C00195
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00196
    Figure US20020013472A1-20020131-C00197
    —(CH2)3—O—C2H5
    Figure US20020013472A1-20020131-C00198
    Figure US20020013472A1-20020131-C00199
    —(CH2)3—O—C2H5
  • Using 3-(2-chloro-phenyl)-2-(4-fluoro-phenyl)-2-[(4,5-dihydro- 5-thiono-1 2,4-triazol-1-yl)-methyl]-oxirane as starting material and 3-ethoxy-propyl isocyanate as reaction component, the course of the process according to the invention can be illustrated by the scheme below. [0020]
    Figure US20020013472A1-20020131-C00200
  • The formula (II) or (IIa) provides a general definition of the oxirane derivatives required as starting materials for carrying out the process according to tile invention. In this formula, R[0021] 1 and R2 preferably have those meanings which have already been mentioned in connection with the description of the substances of tile formnula (I) or (Ia) according to thle invention as being preferred for these radicals.
  • The oxiranie derivatives of thle formula (II) or (IIa) are already known (cf. WO-A 96-39 440). [0022]
  • The formula (III) provides a general definition of the isocyaniates required as reaction components for carrying out the process according to the inveIntion. In this fon-nula, R[0023] 3 preferably has those meanings which have already been mentioned in connection with the description of thle substances of tile formula (I) according to the invention as being preferred for this radical.
  • The isocyaniates of the formula (III) are known or can be prepared by known methods. [0024]
  • Suitable catalysts for carrying out the process according to the invention are all reaction promoters which are customary for such reactions. Preference is given to using amines, such as triethylamine, pyridine, dimethylaminopyridine and diazabicyclo-undecene (DBU). [0025]
  • Suitable diluents for carrying out the process according to the invention are all inert organic solvents which are customary for such reactions. Preference is given to using aromatic hydrocarbons, such as toluene, xylene or decaline, also halogenated hydrocarbons, such as dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichlioroethane, moreover ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane or tetrahydrofuran, and furthermore nitriles, such as acetonitrile, propionitrile, n-or iso-butyronitrile. [0026]
  • When carrying out the process according to the invention, the reaction temperatures can be varied within a certain range. In general, the process is carried out at temperatures between −20° C. and +100° C., preferably between 0° C. and +80° C. [0027]
  • The process according to the invention is generally carried out under atmospheric pressure. However, it is also possible to carry out the process under elevated pressure or, if no highly volatile components are taking part in the reaction, also under reduced pressure. [0028]
  • When carrying out the process according to the invention, in general from I to 1.5 mol of isocyanate of the fomlula (III) and a small amount of catalyst are employed per mole of oxirane derivative of the formula (II) or (IIa). Work-up is carried out by customary methods. In general, the reaction mixture is concentrated under reduced pressure and the product that remains is freed from any impurities that may still be present by customary methods, for example by recrystallization or chromatography. [0029]
  • The compounds according to the invention have a potent microbicidal activity and can be employed for controlling undesirable microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials. [0030]
  • Fungicides are employed in crop protection for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygoniycetes, Ascomycetes, Basidiomycetes and Deuteromycetes. [0031]
  • Bactericides are employed in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae. [0032]
  • Some pathogens causing fungal and bacterial diseases which come under the generic names listed above may be mentioned as examples, but not by way of limitation: [0033]
  • [0034] Xanthonionas species, such as, for example, Xanthomonas campestris pv. oryzae; Pseudomonas species, such as, for example, Pseudomonas syringae pv. lachrymans; Erwinia species, such as, for example, Erwinia amylovora; Pythium species, such as, for example, Pythium ultimum; Phytophtlhora species, such as, for example, Phytoplhthora infestans; Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis; Plasmopara species, such as, for example, Plasmopara viticola; Bremia species, such as, for example, Bremia lactucae, Peronoslpora species, such as, for example, Peronospora pisi or P. brassicae; Erysiphe species, such as, for example, Erysiphe graminis; Sphaerotheca species, such as, for example, Sphaerotheca fuliginea; Podosphaera species, such as, for example, Podosphaera leucotricha; Venturia species, such as, for example, Venturia inaequalis; Pyrenophora species, such as, for example, Pyrenophora tercs or P. graminea (conidia form: Drechslera, syn: Helminthosporium); Cochlioboltis species, such as, for example, Cochiliobolus sativus (conidia form: Drechslera, syn: Helminthosporium); Uromyces species, such as, for example, Uromyces appendiculatus; Puccinia species, such as, for example, Puccinia recondita; Sclerotinia species, such as, for example, Sclerotinia sclerotiorum Tilletia species, such as, for example, Tilletia caries; Ustilago species, such as, for example, Ustilago nuda or Ustilago avenae; Pellicularia species, such as, for example, Pellicularia sasakii; Pyricularia species, such as, for example, Pyricularia oryzae; Fusarium species, such as, for example, Fusarium culmorum; Botrytis species, such as, for example, Botrytis cinerea; Septoria species, such as, for example, Septoria nodorum; Leptosphiaeria species, such as, for example, Leptosphaeria nodorum; Cercospora species, such as, for example, Cercospora canescens; Alternaria species, such as, for example, Altemaria brassicae; and Pseudocercosporella species, such as, for example, Pseudocercosporella herpotrichoides.
  • The fact that the active compounds are well tolerated by plants at the concentrations required for controlling plant diseases permits the treatment of above-ground parts of plants, of propagation stock and seeds, and of the soil. [0035]
  • The active compounds according to the invention can be employed in particular for controlling [0036] Pyticularia oryzae on rice and for controlling cereal diseases, such as Puccinia, Erysipie and Fusarium species. Moreover, the substances according to the invention can be used successfully against Venturia, Podosphaera and Sphaerotheca. They also have very good in-vitro action.
  • The active compounds according to the invention may also be employed to increase the yield of crops. Moreover, they have low toxicity and are well tolerated by plants. [0037]
  • In the protection of materials, the compounds according to the invention can be employed for protecting industrial materials against infection with, and destruction by, undesired microorganisms. [0038]
  • Industrial materials in the present context are understood as meaning non-living materials which have been prepared for use in industry. For example, industrial materials which are intended to be protected by active compounds according to the invention from microbial change or destruction can be adhesives, sizes, paper and board, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be infected with, or decomposed by, microorganisms. Parts of production plants, for example cooling-water circuits, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected. Industrial materials which may be mentioned within the scope of the present invention are preferably adhesives, sizes, paper and board, leather, wood, paints, cooling lubricants and heat-transfer liquids, particularly preferably wood. [0039]
  • Microorganisms capable of degrading or changing the industrial materials which may be mentioned are, for example, bacteria, fungi, yeasts, algae and slime organisms. The active compounds according to the invention preferably act against fungi, in particular moulds, wood-discolouring and wood-destroying fungi ([0040] Basidiomycetes), and against slime organisms and algae.
  • Microorganisms of the following genera may be mentioned as examples: [0041] Alternaria, such as Altemaria tentis, Aspergillus, such as Aslpergillus niger, Chaetomium, such as Chaetomium globosum, Coniophora, such as Coniophora puetania, Lentinus, such as Lentinus tigriitis, Pcenicilliutmi, such as Penicillium glaucum, Polyponis, such as Polyponis vcrsicolor, Aureobasidium, such as Aureobasidium pullulans, Sclerophoma, such as Sclerophoma pityophilIa, Trichoderma, such as Trichioderma viride, Eschierichia, such as Eschericihia coli, Pseudomonas, such as Pseudomonas aeruginosa, and Staphylococcus, such as Staphylococcus aureus.
  • Depending on their particular physical and/or chemical properties, the active compounds can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations. [0042]
  • These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, liquefied gases under pressure, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam fonners. If the extender used is water, it is also possible to use for example organic solvents as auxiliary solvents. The following are mainly suitable as liquid solvents: aromatics such as xylene, toluene or alkylnaptlilialenies, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as clilorobenizenies, cliloroethylenes or methylcne chloride, alipphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, alcohols such as butanlol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylfoniamide or dimethiyl sulphioxide, or else wvater. Liquefied gaseous extenders or carriers are to be understood as meaning liquids which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, or else butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are: for example ground natural minerals such as kaolins, clays, talc, chalk, quartz, attalpulgite, monitirorillonite or cliatomaceous earth, and ground synthetic minerals such as highly disperse silica, alumina and silicates. Suitable solid carriers for granules are: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, or else synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks. Suitable emulsifiers and/or foam formers are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, or else protein hydrolysates. Suitable dispersants are: for example lignin-sulphite waste liquors and methylcellulose. [0043]
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in the formulations. Other additives can be mineral and vegetable oils. [0044]
  • It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phtlialocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. [0045]
  • The formulations generally comprise between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%. [0046]
  • The active compounds according to the invention can be used as such or, in their formulations, also mixed with known fungicides, hactcricidcs, acaricides, nemiiaticides or insecticides in order thus, for example, to Widen the spectrum of action or to prevent development of resistance. In many cases, synergistic effects are achieved here, i.e. the activity of the mixture exceeds the activity of the individual components. [0047]
  • Examples of co-components in mixtures are the following compounds: [0048]
  • Fungicides: aldimorph, ampropylfos, ampropylfos potassium, andoprim, anilazine, azaconazole, azoxystrobin, benalaxyl, benodanil, benomyl, benzamacril, benzamacril-isobutyl, bialaphos, binapacryl, biplienyl, bitertanol, blasticidini-S, bromuconazole, bupirimate, buthiobate, calcium polysuiphide, capsimycin, captafol, captan, carbendazim, carboxin, carvon, quinomethionate, chlobenthiazone, chlorfenazole, chlioroneb, chloropicrin, chlorotlalonil, chlozolinate, clozylacon, cufraneb, cymoxanil, cyproconazole, cyprodinil, cyprofuram, debacarb, dichlioroplhen, diclobutrazole, diclofluanid, diclomezine, dicloran, diethofencarb, difenoconazole, dimethirimol, dimelhonlorph, diniconazole, diniconazole-M, dinocap, diphenylamine, dipyrithione, ditalimfos, dithianon, dodemorph, dodine, drazoxolon, edifenplios, epoxiconazole, etaconazole, etlhirimol, etridiazole, famoxadon, fenapanil, fenarimol, fenbuconazole, fenfuram, fenitropan, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fertiam, ferimzone, fluazinam, flumetover, fluoromide, fluquinconazole, flurprimidol, flusilazole, flisulfaiiiide, flutolaniil, flutriafol, folpet, fosetyl-aluminitim, fosetyl-sodium, fthalide, fuberidazole, furalaxyl, furametpyr, fuircarbonil, furconazole, furconazole-cis, funnecyclox, guazatine, hexaciilorobeiizene, hexaconazole, hymexazole, imazalil, imibenconiazole, iminoctadine, iminoctadine albesilatc, iminoctadine triacetate, iodocarb, ipconazole, iprobcnfos (IBP), iprodione, irmamnycin, isoprothiolane, isovaledione, kasugamycini, kresoxim-inctliyl, copper preparations, suclh as: copper hydroxide, copper naphthenate, copper oxychlioricle, copper sulplhate, copper oxide, oxitie-copper and Bordeaux mixture, mancopper, mancozeb, maneb, meferimzone, mepanipyrim, mepronil, metalaxyl, metconazole, methasulfocarb, mnethfuroxam, mctiram, metomeclam, metsulfovax, mildiomycin, myclobutanil, myclozolin, nickel dimetilyidithiocarbamate, nitrothal-isopropyl, nuarimol, ofurace, oxadixyl, oxamocarb, oxolinic acid, oxycarboxim, oxyfentlliin, paclobutrazole, pefurazoate, penconazole, pencycuron, phosdiphen, pimaricin, piperalin, polyoxin, polyoxorim, probenazole, prochloraz, procymidone, propamocarb, propanosine-sodium, propiconazole, propineb, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, pyroxyfur, quinconazole, quintozene (PCNB), sulphur and sulphur preparations, tebuconazole, tecloftalain, tecnazene, tetcyclasis, tetraconazole, thiabendazole, thicyofen, thiifluzamide, thiophanate-methyl, thiram, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triazbutil, triazoxide, tricilamide, tricyclazole, tridemorph, triflumizole, triforine, triticotiazole, Linicoiiazole, validarnycin A, vinclozolin, viniconazole, zarilamide, zineb, zirain and also Dagger G, OK-8705, OK-8801, α-(1,1-dimethylethlyl)-β-(2-plienoxyethyl)- 1H-1,2,4-triazole-1-ethanol, α-(2,4-dichlorophenyl)-β-fluoro-b-propyl-1H-1,2,4-triazoIe-1 -etlianol, α-(2,4-dichlIoropihciiyl)-β-methoxy-a-methyl-H1,2,4-triazole-1-ethanol, α-(5-methyl-1,3-dioxan5-yl)-β-[[4-(trifluoromethyl)-phenyl]-methylene-]-1H-1,2,4-triazole-1-ethanol, (5RS,6RS)-6-hydroxy-2,2,7,7-tetranietihyl-5-( 1H-1,2,4-triazol-1-yl)-3-octanone, (E)-a-(methoxyimino)-N-methyl-2-phenoxy-phenylacetamide, isopropyl {2-methyl-1-[[[1-(4-methylphenyl)-ethyl]-amino]-carbonyl]-propyl}-carbamate, 1-(2,4-dichlorophenyl)-2-(1H,1,2,4-triazol-1-yl)-ethanone ◯-(phenylmenthyl) oxime, 1-(2-methyl-1-naphthalenyl)-1H-pyrrole-2,5-dione, 1-[(3,5-diclhlorophenyl)-3-(2-propenyl)-2,5-pyrrold(1incdione, 1-[(diiodomethyl)-sulphonyl]-4-methyl-benzene, 1-[[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]-methyl]-1H-imidazole, 1-[[2-(4-chlorophenyl)-3-phenyloxiranyl]-methyl]-1H-1,2,4-triazole, 1-[-[2-[(2,4-dichlorophenyl)-methoxy]-phenyl]-ethenyl]-1H-imidazole, 1-methyl-5-nonyl-2-(phenlylmethyl)-3-pyrrolidinole, 2′,6′-dibromo-2-methyl-4′-trifluoromethoxy-4′-trifluoro-methyl-1,3-thiazole-5-carboxanilide, 2,2-dichloro-N-[1-(4-chlorophenyl)-ethyl]-1-ethyl-3-methyl-cyclopropaiiecarboxamide, 2,6-dichloro-5-(methylthio)-4-pyrimidinyl-thiocyanate, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, 2,6-dicliloro-N-[[4-(trifluoromethyl)-phenyl]-methyl]-benzamide, 2-(2,3,3-triiodo-2-propenyl)-2H-tetrazole, 2-[(1-methylethyl)-sulphonyl]-5-(trichloromethyl)-1,3,4-thiadiazole, 2-[[6-deoxy-4-◯-(4-◯-methyl-Γ-D-glycopyranosyl)-a-D-glucopyranosyl]-aminol]-4-methoxy-1H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 2-amninobutane, 2-bromo-2-(bromomethyl)-pentanedinitrile, 2-chltoro-N-(2,3-dihydro-1,1,3-trimethyl-III-inden-4-yl)-3-pyridinecarboxamide, 2-cloro-N-(2,6-dimethylphenyl)-N-(isothiocyanatomethyl)-acetamide, 2-phenylphenol (OPP), 3,4-dichloro-1-[4-(difluoromethoxy)-phenyl]-III-pyrrole-2,5-dione, 3,5-dictiloro-N-[cyano-[(1-methyl-2-propynyl)-oxy]-methyl]-benzamide, 3-(1,1 -dimethlypropyl-1-oxo-III-indene-2-carbonitrile, 3[2-(4-chlorophenyl)-5-ethoxy-3-isoxazoldinyl]-pyridine, 4-chloro-2-cyano-N,N-dimethyl-5-(4-methyphenyl)-1H-imidazole-1-sulphonamide, 4-methyl-tetrazolo[1 ,5-a]quinazolin-5(4H)-one, 8-(1,1 -dimenthylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro[4.5]decane-2-methanamine, 8-hydroxyquinoline sulphate, 9H-xanthlene-2-[(phenylamino)-carbonyl]-9-carboxylic hydrazide, bis-(1-methylethyl)-3-methyl-4-[(3-methylbenzoyl)-oxy]-2,5-thiophenedicarboxylate, cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol, cis-4-[3 -[4-(1,1 -dimethylpropyl)-phenyl-2-methylpropyl]-2,6-dimethyl-morpholinehydrochloride, ethyl [(4-chlorophenyl)-azo]-cyanoacetate, potassium hydrogen carbonate, methanetetrathiol sodium salt, methyl 1-(2,3-dihydro-2,2-dimethyl-1H-inden-1-yl)-1H-imidazole-5-carboxylate, methyl N-(2,6-dimethylphenyl)-N-(5-isoxazolylcarbonyl)-DL-alaninate, methyl N-(chloroacetyl)-N-(2,6-dimethylphenyl)-DL-alaninate, N-(2,3-dichloro-4-hydroxyphenyl)-1-methyl-cyclohexanecarbox am ide, N-(2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-furanyl)-acetamide, N-(2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-thienyt)-acetamide, N-(2-chloro-4-nitrophenyl)-4-methyl-3-nitro-benzenesulplhonamide, N-(4-cycloliexylphenyl)-1,4,5,6-tetralhydro-2-pyrimidinamine, N-(4-hexylphenyl)- 1,4,5,6-tetrahydro-2-pyrimidiniamine, N-(5-chloro-2-methoxyplenyl) )-2 -methoxy-N-(2-oxo-3-oxazolidinyl)-acetamide, N-(6-methoxy)-3-pyridinyl)-cyclopropanecarzoxamide, N- 2,2,2-trichoro-1-[(chloroacetyl)-anino]-ethyl ]-benzanide, N-[3-chloro-4,5-bis(2-propinyloxy)-phenyl]-N′-methoxy-methanimidamide, N-formyl-N-hydroxy-DL-alanine sodium salt, ◯,◯-diethyl [2-(dipropylamlitio)-2-oxoethlyl]-ethylphosphoramidothioate, ◯-methyl S-phenyl phenylphosphoramidothioate, S-methyl 1,2,3-benzothiadiazole-7-carbothioate, spiro[2H]-1-1 -benzopyranr-2,1′(3′H)-isobenzofuran]-3′-one, [0049]
  • Bactericides: [0050]
  • bromopol, dichloroplien, nitrapyrin, nickel dimietlhylditliocarbarnate, kasugamycin, octhliinoaie, furancarhoxylic acid, oxytetracyclin, probeiiazole, strcptomycin, tecloftalam, copper sulphiate and other copper preparations. [0051]
  • Insecticides/Acaricides/Nematicides: [0052]
  • abamectin, acephate, acrinathrin, alanycarb, aldicarb, alphamethrin, amitraz, avernectin, AZ 60541, azadirachtin, azinphos A, azinphos M, azocyclotin, [0053] Bacillus thuringiensis, 4-bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(tri-fluoromethyl)-1H-pyrrole-3-carbonitrile, bendiocarb, benfuracarb, bensultap, betacyfluthirin, bifenthrin, BPMC, brofenprox, bromophos A, bufencarb, buprofezin, butocarboxim, butylpyridaben, cadusafos, carbaryl, carbofuran, carbophenotlhion, carbosulfan, cartap, chloethocarb, chlorethoxyfos, chlorfenapyr, chlorfenvinplhos, chlorfluazuron, chlormephos, N-[(6-chloro-3-pyridinyl)-methyl]-N′-cyano-N-methyl-etlianimidamide, chlorpyrifos, chlorpyrifos M, cis-resmethrin, clocythrin, clofentezine, cyanophos, cycloprothrin, cyfluthrin, cyhalothrin, cyhexatin, cypernethrin, cyromazine, deltamethrin, demeton M, demeton S, demeton S-methyl, diafenthiuron, diazinon, dichlofentliion, dichliorvos, dicliphos, dicrotophos, diethion, diflubenzuron, dimethoate, dimethylvinphos, dioxatlhion, disulfoton, edifenphos, emamectin, esfenvalerate, ethiofencarb, ethion, ethofenprox, ethoprophos, etrimpllos, fenamiphos, fenazaquin, fenbutatin oxide, feiiitrothion, fenobucarb, fenothiocarb, fenoxycarb, fenpropatlnrin, fenpyrad, fenpyroximiiate, fenthion, fenvalerate, fipronil, fluazinam, fluazuron, flucycloxuron, flucyihriinate, flufenoxuron, flufenprox, fluvalinate, fonophos, fonnothion, fosthiazate, fubferiprox, furathiocarb, IICII, hepteniophios, hexaflurnuron, hexythiazox, irnidacloprid, iprobenfos, isazophos, isofenphos, isoprocarb, isoxathion, ivernectin, lambda-cylhalothlrin, lufenLuron, malathion, mecarbam, mevinphos, mesulfenphos, metaldehyde, methacrifos, methamidophos, methidathion, methiocarb, methomyl, metolcarb, milbemectin, monocrotophos, moxidectin, naled, NC 184, nitenpyram, omethoate, oxamyl, oxydemthon M, Oxdeprofos parathion A, parathion M, permethrin, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos M, pirimiphos A, profenofos, promecarb, propaphos, propoxur, prothiofos, prothoate, pymetrozin, pyrachlophos, pyridaphenthion, pyresmethrin, pyrethrum, pyridaben, pyrimidifen, pyriproxifen, quinalphos, salithion, sebufos, silafluofen, sulfotep, suiprofos, tebufenozide, tebufenpyrad, tebupirimiphos, teflubenzuron, tefluthrin, temephos, terbam, terbufos, tetrachlorvinphos, tlhiafenox, thiodicarb, thiofanox, thiomethon, thionazin, thuringiensin, tralomethrin, triarathen, triazophos, triazuron, trichlorfon, triflumuron, trimethacarb, vamidothion, XMC, xylylcarb, zetamethrin.
  • It is also possible to admix other known active compounds, such as herbicides, fertilizers and growth-regulating substances. [0054]
  • The active compounds can be used as such or in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. They are used in the customary manner, for example by pouring, spraying, atomizing, spreading, dusting, foaming, bnishilg on and the like. It is further possible to apply the active compounds by the ultra-low volume method or to inject the active compound formulation, or the active compound itself, into the soil. The seeds of the plants can also be treated. [0055]
  • When using the active compounds according to the invention as fungicides, the application rates can be varied within a relatively wide range, depending on the type of application. In the treatment of parts of plants, the active compound application rates are generally between 0.1 and 10,000 g/ha, prefcrably between 10 and 1000 g/ha. In the treatment of seeds, the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably bctwecn 0.01 and 10 g per kilogram of seed. In the treatment of the soil, the active compound application rates are generally between 0.1 and 10,000 gha, preferably between 1 and 5000 g/ha. [0056]
  • The compositions used for protecting industrial materials generally comprise the active compounds in an amount of from 1 to 95% by weight, preferably from 10 to 75% by weight. [0057]
  • The use concentrations of the active compounds according to the invention depend on the species and the occurrence of the microorganisms to be controlled, and on the composition of the material to be protected. The optimum amount to be used can be determined by test series. In general, the use concentrations are in the range from 0.001 to 5% by weight, preferably from 0.05 to 1.0% by weight, based on the material to be protected. [0058]
  • It is possible to increase the activity and the activity spectrum of the active compounds to be used according to the invention in the protection of materials, or of the compositions, concentrates or, quite generally, formulations preparable therefrom, by adding, if appropriate, other antimicrobially active compounds, fungicides, bactericides, herbicides, insecticides or other active compounds to increase the activity spectrum or to obtain effects, such as, for example, additional protection against insects. These mixtures may have a broader activity spectrum than the compounds according to the invention. [0059]
  • The preparation and the use of active compounds according to the invention are illustrated by the examples below. [0060]
  • Preparation examples[0061]
  • EXAMPLE 1
  • [0062]
    Figure US20020013472A1-20020131-C00201
  • At room temperature and with stirring, a solution of 110 mg (0.97 mmol) of 3-ethoxy-propyl isocyanate in 5 ml of absolute tetrahydrofuran is added dropwise to a mixture of 350 mg (0.97 mmol) of 3-(2-chloro-phenyl)-2-(4-fluoro-phenyl)-2-[(4,5-dilhydro-5-thiono-1,2,4-triazol-1-yl)-methyl]-oxirane, 0.1 ml of triethylamine and 5 ml of absolute tetrahydrofuran. After the addition has ended, the reaction mixture is heated at 60° C. for one hour and then concentrated under reduced pressure. The product that remains is chromatograplhed over silica gel using a mixture of cyclohexane/ethyl acetate =4:1. Concentration of the eluate gives 390 mg (82% of theory) of the substance of the formula shown above. [0063] 1H-NMR spectrum (300 MHz, CDCI3, TMS):
  • δ=10.0 (s, 1H); 8.4 (s, 1H); 7.6-7.3 (m, 6H); 7.0 (t, 2H, J=8.7 Hz); 5.1 )d, 1H, [0064]
  • J=14.9 Hz); 4.1 (s, 1H); 3.7 (d, 1H, J=14.9 Hz); 3.5-3.4 (m, 6H); 1.9-1.8 (m, [0065]
  • 2H); 1.2 (t, 3H, J=7.0 Hz) ppm. [0066]
  • The compounds listed in the table below are likewise prepared by the method shown in Example 1: [0067]
    TABLE 2
    (I)
    Figure US20020013472A1-20020131-C00202
    Example Melting point
    No. R1 R2 R3 in ° C.
    2
    Figure US20020013472A1-20020131-C00203
    Figure US20020013472A1-20020131-C00204
    —CH2—CH2—O—CH3 105-107
    3
    Figure US20020013472A1-20020131-C00205
    Figure US20020013472A1-20020131-C00206
    —CH(CH3)2 104-106
    4
    Figure US20020013472A1-20020131-C00207
    Figure US20020013472A1-20020131-C00208
    —C12H25-n 53-57
    5
    Figure US20020013472A1-20020131-C00209
    Figure US20020013472A1-20020131-C00210
    —CH(CH3)2 100-101
    6
    Figure US20020013472A1-20020131-C00211
    Figure US20020013472A1-20020131-C00212
    —CH2—CH2—O—CH3 96-98
  • EXAMPLE 7
  • [0068]
    Figure US20020013472A1-20020131-C00213
  • [0069] 1H-NMR spectrum (400 MHz, CDCl3, TMS): δ=7.8 (s, 1H); 7.3-7.1 (m, 4H); 7.0-6.9 (m, 4H); 6.7 (s, 1H);5.0 (d, 1H); 4.5 (s, 1H); 3.7 (m, 1H); 1.0 (d, 6H, J=6.6 Hz) ppm.
  • Use examples [0070]
  • EXAMPLE A [0071]
  • Erysiphe test (barley)/protective Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0072]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0073]
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. [0074]
  • After the spray coating has dried on, the plants are dusted with spores of [0075] Erysiphe graminis f.sp. hordei.
  • The plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules. [0076]
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, vhereas an efficacy of 100% means that no infections are observed. [0077]
  • Active compounds, application rates and test results are shown in the table below. [0078]
    TABLE A
    Erysiphe test (barley)/protective
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00214
    125 100
    (2)
    Figure US20020013472A1-20020131-C00215
    125 100
    (3)
    Figure US20020013472A1-20020131-C00216
    125 100
    (4)
    Figure US20020013472A1-20020131-C00217
    125 100
  • EXAMPLE B [0079]
  • Erysiplie test (barley)/curative Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0080]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0081]
  • To test for curative activity, young plants are dusted with spores of [0082] Erysiphe graminis f.sp. hordei. 48 hours after the inoculation, the plants are sprayed with the preparation of active compound at the stated application rate.
  • The plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules. [0083]
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0084]
  • Active compounds, application rates and test results are shown in the table below. [0085]
    TABLE B
    Erysiphe test (barley)/curative
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00218
    250 100
    (4)
    Figure US20020013472A1-20020131-C00219
    250 100
  • EXAMPLE [0086]
  • Erysiphe test (wheat)/protective Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0087]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0088]
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. [0089]
  • After the spray coating has dried on, the plants are dusted with spores of [0090] Erysiphe graminis f.sp. tritici.
  • The plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of mildew pustules. [0091]
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0092]
  • Active compounds, application rates and test results are shown in the table below. [0093]
    TABLE C
    Erysiphe test (wheat)/protective
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00220
    250 100
    (3)
    Figure US20020013472A1-20020131-C00221
    250 100
    (4)
    Figure US20020013472A1-20020131-C00222
    250 100
  • EXAMPLE D [0094]
  • Leptosphaeria nodorum test (wheat)/protective Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0095]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0096]
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are dusted with a spore suspension of Leptosphaeria nodorum. The plants remain in an incubation cabin at 20° C. and 100% relative atmospheric humidity for 48 hours. [0097]
  • The plants are placed in a greenhouse at a temperature of approximately 15° C. and a relative atmospheric humidity of 80%. [0098]
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0099]
  • Active compounds, application rates and test results are shown in the table below. [0100]
    TABLE D
    Leptosphaeria nodorum test (wheat)/protective
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    (1)
    Figure US20020013472A1-20020131-C00223
    250 100
  • EXAMPLE E [0101]
  • Puccinia test (wheat)/curative Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0102]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0103]
  • To test for curative activity, young plants are sprayed with a [0104] Conidia suspension of Puccinia recondite. The plants remain in an incubation cabin at 20° C. and 100% relative atmospheric humidity for 48 hours. The plants are then sprayed with the preparation of active compound at the stated application rate.
  • The plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of rust pustules. [0105]
  • Evaluation is carried out 10 days after tile inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0106]
  • Active compounds, application rates and test results are shown in the table below. [0107]
    TABLE E
    Puccinia test (wheat)/curative
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00224
    125 100
    (2)
    Figure US20020013472A1-20020131-C00225
    125 100
    (3)
    Figure US20020013472A1-20020131-C00226
    125 100
    (4)
    Figure US20020013472A1-20020131-C00227
    125 100
  • EXAMPLE F [0108]
  • Puccinia test (wheat)/protective Solvent: 25 parts by weight of N,N-dimethylacetamide Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether [0109]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0110]
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are sprayed with a [0111] Conidia suspension of Puccinia recondita. The plants remain in an incubation cabin at 20° C. and 100% relative atmospheric humidity for 48 hours.
  • The plants are placed in a greenhouse at a temperature of approximately 20° C. and a relative atmospheric humidity of approximately 80% to promote the development of rust pustules. [0112]
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0113]
  • Active compounds, application rates and test results are shown in the table below. [0114]
    TABLE F
    Puccinia test (wheat)/protective
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00228
    125 100
    (2)
    Figure US20020013472A1-20020131-C00229
    125 100
    (4)
    Figure US20020013472A1-20020131-C00230
    125 100
  • EXAMPLE G [0115]
  • Podosphaera test (apple)/protective Solvent: 47 parts by weight of acetone Emulsifier: 3 parts by weight of alkylaryl polyglycol ether [0116]
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. [0117]
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are inoculated with an aqueous spore suspension of the causative organism of apple mildew [0118] Podosphaera leucotricha. The plants are then placed in a greenhouse at approximately 23° C. and a relative atmospheric humidity of approximately 70%.
  • Evaluation was carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infections are observed. [0119]
  • Active compounds, application rates and test results are shown in the table below. [0120]
    TABLE G
    Podosphaera test (apple)/protective
    Active
    compound
    application rate
    Active compound g/ha Efficacy in %
    Known from WO-A 96-38440:
    (A)
    Figure US20020013472A1-20020131-C00231
    10  1 92 57
    According to the invention:
    (1)
    Figure US20020013472A1-20020131-C00232
    10  1 100 65
    (2)
    Figure US20020013472A1-20020131-C00233
    10  1 100 88
    (3)
    Figure US20020013472A1-20020131-C00234
    10  1 100 80
    (4)
    Figure US20020013472A1-20020131-C00235
    10 100
  • EXAMPLE H [0121]
  • Inhibition test on giant colonies of Basidiomycetes Solvent: Dimethylsulphoxide [0122]
  • To produce a suitable preparation of active compound, 0.2 parts by weight of active compound are admixed to 99.8 parts by weight of the abovementioned solvent. [0123]
  • An agar, prepared by using malt extract peptone, is mixed in a liquid state with the preparation of active compound at the particular desired application rate. After solidification, the resultant nutrient medium is incubated at 26° C. with mycelium pieces punched out of colonies of [0124] Coriolus versicolor.
  • Evaluation is carried out after 3 or 7 days' storage at 26° C. by measuring the growth of the mycelium and scoring the resulting inhibition in percent in comparison to the untreated control. 0% means an inhibition of growth which corresponds to that of the untreated control, while an inhibition of growth of 100% means that no growth of mycelium is observed. [0125]
  • Active compounds, active compound concentrations and test results are shown in the table below. [0126]
    TABLE H
    Inhibition test on giant colonies of Basidiomycetes
    Inhibition in per cent of radial growth of giant
    colonies at 6 ppm of active compound according to
    Example
    Fungal species (1) (3) (5)
    Coriolus versicolor 100 100 100

Claims (10)

1. Oxiranyl-triazolinethioneg of the formula
Figure US20020013472A1-20020131-C00236
in which
R1 represents alkyl having 1 to 4 carbon atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, optionally halogen-substituted cycloalkyl having 3 to 7 carbon atoms, naphthyl or phenyl which is optionally mono-to trisubstituted by identical or different substituents from the group consisting of halogen, nitro, phenyl, phenoxy, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, halogenoalkoxy having 1 to 4 carbon atoms and 1 to 5 halogen atoms and halogenoalkylthlio having 1 to 4 carbon atoms and 1 to 5 halogen atoms,
R2 represents plienyl which is optionally mono-to trisubstituted by identical or different substituents from the grotip consisting of halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, halogenoalkyl having 1 to 4 carbon atoms and 1 to 5 alogen atoms, halogenoalkoxy having 1 to 4 carbon atoms and 1 to 5 halogen atoms and halogenoalkylthio having 1 to 4 carbon atoms and 1 to 5 halogen atoms and R3 represents alkoxyalkyl, isopropyl or n-dodecyl.
2. Oxiranyl-triazolinethioneiof the formula (I) For (la) according to claim I in which
R1represents methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, fluoro-tert-butyl, difluoro-tert-butyl, cycloalkyl having three to six carbon atoms which is optionally mono- to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine and bromine, represents naphthyl or represents phenyl which may be mono- to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, nitro, phenyl, phenoxy, methyl, ethyl, tert-butyl, methoxy, ethoxy, trifluoromethyl, trichlioromethyl, difluoromethyl, difluoro-chloromethyl, trifluoromethoxy, difluoromethoxy and tri fluorometlhylthio, R2 represents phenyl which may be mono- to trisubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, methyl, ethyl, isopropyl, tert-butyl, methoxy, ethoxy, trifluoromethlyl, trichloromethyl, difluorometlhyl, difluoroclhlorometliyl, triluoromethoxy, difluoromethoxy and trinfluoromethyltlhio, and R3 represents alkoxyalkyl having 1 to 6 carbon atoms in the alkoxy moiety and 1 to 6 carbon atoms in the alkyl moiety and also represents isopropyl or n-dodecyl.
3. Process for preparing oxiranyl-triazolinethiones of the formula (I) or (Ia) according to claim 1, characterized in that oxirane derivatives of the formula
Figure US20020013472A1-20020131-C00237
in which R1 and R2 are each as defined above are reacted with isocyanates of the formula
R3-NCO  (III)
in which R3 is as defined above,
if appropriate in the presence of a catalyst and if appropriate in the presence of a diluent.
4. Microbicidal compositiorns, characterized in that they comprise at least one oxiranyl-triazolinethione of the formula (I) or (Ia) according to claim 1, in addition to extenders and/or surfactants.
5. Use of oxiranyl-triazoline,liioiies of the formula (I) or (Ia) according to claim 1 as microbicides in crop protection and in the protection of materials.
6. Method for controlling undesirable microorganisms in crop protection and in the protection of materials, characterized in that oxiranyl-tnazolinethmones of and/or their habitat.
7. Process for preparing microbioidal compositions, characterized in that the oxiranyl-triazolinethiona of the formula (I) or (Ia) according to claim 1 are mixed with extenders and/or surfactants.
8. Oxiranyl-triazolinethione according to claim 1, characterized by the formula
Figure US20020013472A1-20020131-C00238
9. Oxiranyl-triazolinethione according to claim 1, characterized by the formula
Figure US20020013472A1-20020131-C00239
10. Oxiranyl-triazolinethione according to claim 1, characterized by the formula
Figure US20020013472A1-20020131-C00240
US09/827,058 1997-10-24 2001-04-05 Oxiranyl-triazoline thiones and their use as microbicides Expired - Fee Related US6414007B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/827,058 US6414007B2 (en) 1997-10-24 2001-04-05 Oxiranyl-triazoline thiones and their use as microbicides

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE19746993 1997-10-24
DE19746993 1997-10-24
DE19746993.0 1997-10-24
DE19823861.4 1998-05-28
DE19823861A DE19823861A1 (en) 1997-10-24 1998-05-28 New 1-oxiranylmethyl-4-carbamoyl-1H-1,2,4-triazole-5-thione derivatives
DE19823861 1998-05-28
US09/529,678 US6245793B1 (en) 1997-10-24 1998-10-12 Oxyranyle-triazoline thiones and their use as microbicides
US09/827,058 US6414007B2 (en) 1997-10-24 2001-04-05 Oxiranyl-triazoline thiones and their use as microbicides

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP1998/006449 Division WO1999021853A1 (en) 1997-10-24 1998-10-12 Oxyranyle-triazoline thiones and their use as microbicides
US09/529,678 Division US6245793B1 (en) 1997-10-24 1998-10-12 Oxyranyle-triazoline thiones and their use as microbicides

Publications (2)

Publication Number Publication Date
US20020013472A1 true US20020013472A1 (en) 2002-01-31
US6414007B2 US6414007B2 (en) 2002-07-02

Family

ID=26041057

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/529,678 Expired - Fee Related US6245793B1 (en) 1997-10-24 1998-10-12 Oxyranyle-triazoline thiones and their use as microbicides
US09/827,058 Expired - Fee Related US6414007B2 (en) 1997-10-24 2001-04-05 Oxiranyl-triazoline thiones and their use as microbicides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/529,678 Expired - Fee Related US6245793B1 (en) 1997-10-24 1998-10-12 Oxyranyle-triazoline thiones and their use as microbicides

Country Status (13)

Country Link
US (2) US6245793B1 (en)
EP (1) EP1060176B1 (en)
JP (1) JP2001521031A (en)
KR (1) KR20010031064A (en)
CN (1) CN1152875C (en)
AT (1) ATE267195T1 (en)
AU (1) AU1227699A (en)
BR (1) BR9813261A (en)
DE (1) DE59811437D1 (en)
HU (1) HUP0003811A3 (en)
IL (1) IL135316A (en)
MX (1) MX210235B (en)
WO (1) WO1999021853A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9049865B2 (en) 2010-04-14 2015-06-09 Bayer Intellectual Property Gmbh Use of fungicidal active substances for controlling mycoses on plants of the palm family

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201000950A1 (en) * 2007-12-19 2011-02-28 Басф Се AZOLYLMETHYLOXYRANES, THEIR APPLICATION, AND ALSO CONTAINING THEM
JP2011506543A (en) * 2007-12-19 2011-03-03 ビーエーエスエフ ソシエタス・ヨーロピア Azolylmethyloxirane, its use and medicaments containing it
WO2009077471A2 (en) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxiranes, use thereof and agents containing the same
US20110190122A1 (en) * 2008-10-07 2011-08-04 Basf Se Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them
BRPI0920683A2 (en) * 2008-10-07 2015-08-18 Basf Se Compound, composition of active compound, seed, drug, and methods for controlling phytopathogenic fungi, and for preparing an antimycotic agent.
WO2010146029A2 (en) * 2009-06-16 2010-12-23 Basf Se Fungicidal mixtures
WO2011069912A1 (en) 2009-12-07 2011-06-16 Basf Se Triazole compounds, use thereof and agents containing said compounds
WO2011069916A1 (en) 2009-12-08 2011-06-16 Basf Se Triazole compounds, use thereof as a fungicide, and agents comprising same
WO2011069894A1 (en) 2009-12-08 2011-06-16 Basf Se Triazole compounds, use thereof, and agents containing same
CN102753536A (en) * 2009-12-18 2012-10-24 巴斯夫欧洲公司 Method for producing triazolinthione derivatives and intermediates thereof
AR080525A1 (en) 2010-03-16 2012-04-11 Basf Se A PROCESS USING GRIGNARD REAGENTS
EP2621922A1 (en) 2010-09-30 2013-08-07 Basf Se A process for the synthesis of thio-triazolo-group containing compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218130A1 (en) 1982-05-14 1983-11-17 Basf Ag, 6700 Ludwigshafen AZOLYL METHYLOXIRANES, METHOD FOR THE PRODUCTION THEREOF AND FUNGICIDES CONTAINING THEM
IL78175A (en) 1985-03-29 1989-10-31 Basf Ag Azolylmethyloxiranes,their preparation and their use as fungicide crop protection agents
DE3511411A1 (en) 1985-03-29 1986-10-02 Basf Ag, 6700 Ludwigshafen USE OF AZOLYLMETHYLOXIRANES TO COMBAT VIRAL DISEASES
US4729986A (en) * 1986-04-24 1988-03-08 E. I. Du Pont De Nemours And Company Fungicidal triazoles and imidazoles
SG47444A1 (en) 1991-12-19 1998-04-17 Ciba Geigy Ag Microbicides
DE19520097A1 (en) 1995-06-01 1996-12-05 Bayer Ag Triazolylmethyl oxiranes
DE19520095A1 (en) * 1995-06-01 1996-12-05 Bayer Ag New 1-((tri- substd.)silyl)methyl-1,2,4-triazole-5-thiol derivs.
DE19617461A1 (en) * 1996-05-02 1997-11-06 Bayer Ag Acylmercapto triazolyl derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9049865B2 (en) 2010-04-14 2015-06-09 Bayer Intellectual Property Gmbh Use of fungicidal active substances for controlling mycoses on plants of the palm family

Also Published As

Publication number Publication date
IL135316A (en) 2003-05-29
MXPA00003538A (en) 2001-01-31
ATE267195T1 (en) 2004-06-15
AU1227699A (en) 1999-05-17
CN1277609A (en) 2000-12-20
EP1060176A1 (en) 2000-12-20
WO1999021853A1 (en) 1999-05-06
BR9813261A (en) 2000-08-22
KR20010031064A (en) 2001-04-16
JP2001521031A (en) 2001-11-06
EP1060176B1 (en) 2004-05-19
CN1152875C (en) 2004-06-09
MX210235B (en) 2002-09-09
US6414007B2 (en) 2002-07-02
HUP0003811A2 (en) 2001-03-28
IL135316A0 (en) 2001-05-20
HUP0003811A3 (en) 2002-01-28
US6245793B1 (en) 2001-06-12
DE59811437D1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
US6262039B1 (en) Triazolinethione-phosphoric acid derivatives
JP2011144187A (en) Pyrazole carboxyanilide bactericide/fungicide
US6107336A (en) Dihydrofuran carboxamides
US6245793B1 (en) Oxyranyle-triazoline thiones and their use as microbicides
US6054473A (en) 1,3-dimethyl-5-fluoro-pyrazole-4-carboxamide derivatives, their preparation and their use as microbicides
US6043377A (en) Imidazole compounds
US6090831A (en) Use of sulfonyloxadiazolones as microbicides
US6632817B2 (en) Fluoromethoximino compounds
US6444612B1 (en) Use of 5-amino-pyrazol-derivatives for combating micro-organisms
US6013664A (en) Microbicidal agents based on thiophene-2-carboxylic acid derivatives
US6100281A (en) Sulphonyloxadiazolones
US6410600B1 (en) Azine used as fungicides
US6180655B1 (en) Sulfonyl benzazolones
US6136830A (en) Sulphonyloxadiazolones and their use as microbicides
US6262051B1 (en) Fungicidal methoximinomethyldioxazines
US6407097B1 (en) Methoximinomethyloxathiazines
US6566383B2 (en) Sulfonyltriazol derivatives and their use for combating micro-organisms
US6359142B1 (en) Sulfonyl oxazolones and their use for combating undesirable microorganisms
US6350909B1 (en) Methoxymino-phenylacetamide derivatives and their utilization as pesticides
US6348471B1 (en) Pyrimidyl oxyphenylacetic acid derivatives
WO2001034576A2 (en) Use of pyrimidinone derivatives for controlling undesired microorganisms
JP2001512719A (en) Triazoline-thione derivatives and their use as microbicides

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060702